MANHASSET, NY – At North Shore University Hospital’s Stroke Center, a US Food and Drug Administration-approved Solitaire™ Flow Restoration (FR) revascularization device is now available to patients suffering from acute ischemic stroke.
Jeffrey Katz, MD, chief of vascular neurology and director of the Stroke Center at North Shore University Hospital (NSUH), recently used the Solitaire™ FR device in 47- -year-old Richard Hasselberger from Manhasset, NY, who presented with a spontaneous carotid dissection and ischemic stroke.
“The Solitaire™ device is relatively easier to use than the older technology we have been accustomed to and has the potential to open blood vessels more rapidly than previous devices,” said Dr. Katz. “This is important because ‘time is brain’ when treating stroke patients. In the randomized trial comparing the new Solitaire™ device to the Merci retriever, patients treated with Solitaire™ had excellent clinical outcomes, which is what we have seen in the first two patients we treated.”
The Solitaire™ FR is a self-expanding, columnar metal cage device combining the ability to restore blood flow to the brain, administer medical therapy and retrieve the blood clot. Treatment with Solitaire™ allows the interventional neurologist to reopen target arteries in a much more effective and efficient way, resulting in less symptomatic intracranial hemorrhage and better neurologic outcomes by three months after the stroke.
About the Stroke Center at North Shore University Hospital:
The Stroke Center, part of Cushing Neuroscience Institute at North Shore-LIJ Health System, is a member of a vast network of New York State-designated stroke centers that are committed to excellence and quality in stroke care and services. By utilizing medications like Tissue Plasminogen Activator (tPA), a “clot-buster," our stroke teams are improving the outcome of stroke patients.
North Shore University Hospital is the only Comprehensive Stroke Center within the North Shore-LIJ Health System and offers cutting-edge stroke interventions that are not widely available. Such aggressive and effective treatments include intra-arterial thrombolytic, clot-removal and endovascular retrieval devices. North Shore University Hospital is also one of only three hospitals on Long Island to have earned a prestigious Certificate of Distinction from the Joint Commission for Advanced Certification as a Primary Stroke Center. For more information about the Stroke Center, call (516) 562-3064 or visit www.neurocni.com